Movement Alert｜Elevance Health Rises 5.25% in Pre-Market Trading, Multiple Investment Banks Raise Price Targets Ahead of Q2 Earnings

Market Focus

07/14

On July 14, Elevance Health rose 5.25% in pre-market trading, trading at $442.15/share, with turnover of $334,800. The rally came as multiple Wall Street firms issued bullish price target revisions just ahead of the company's Q2 earnings release scheduled for July 15.

On the news front, Wells Fargo significantly raised its price target from $391 to $492 while maintaining an Overweight rating; Truist lifted its target to $475, keeping a Buy rating; and Bernstein raised its target to $482, maintaining an Outperform rating. The FactSet consensus target price has climbed to approximately $439. Market consensus expects Q2 revenue of $48.714 billion, representing 0.99% year-over-year growth, with adjusted EPS of $6.20.

The broader healthcare insurance sector is approaching a critical test as Elevance, UnitedHealth, and CVS Health report Q2 results sequentially. Goldman Sachs noted that underwriting conditions for managed care companies are improving. Elevance delivered a strong Q1 beat with adjusted EPS of $12.58 versus the $10.79 estimate, and management reaffirmed full-year adjusted EPS guidance of at least $26.75.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1105657461"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1105657461\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1105657461?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-14 21:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1105657461","market":"us","top_or_hot":-1,"title":"Movement Alert｜Elevance Health Rises 5.25% in Pre-Market Trading, Multiple Investment Banks Raise Price Targets Ahead of Q2 Earnings","media":"Market Focus","content":"<p><p>On July 14, Elevance Health rose 5.25% in pre-market trading, trading at $442.15/share, with turnover of $334,800. The rally came as multiple Wall Street firms issued bullish price target revisions just ahead of the company's Q2 earnings release scheduled for July 15.</p><p>On the news front, Wells Fargo significantly raised its price target from $391 to $492 while maintaining an Overweight rating; Truist lifted its target to $475, keeping a Buy rating; and Bernstein raised its target to $482, maintaining an Outperform rating. The FactSet consensus target price has climbed to approximately $439. Market consensus expects Q2 revenue of $48.714 billion, representing 0.99% year-over-year growth, with adjusted EPS of $6.20.</p><p>The broader healthcare insurance sector is approaching a critical test as Elevance, UnitedHealth, and CVS Health report Q2 results sequentially. Goldman Sachs noted that underwriting conditions for managed care companies are improving. Elevance delivered a strong Q1 beat with adjusted EPS of $12.58 versus the $10.79 estimate, and management reaffirmed full-year adjusted EPS guidance of at least $26.75.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Elevance Health Rises 5.25% in Pre-Market Trading, Multiple Investment Banks Raise Price Targets Ahead of Q2 Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Elevance Health Rises 5.25% in Pre-Market Trading, Multiple Investment Banks Raise Price Targets Ahead of Q2 Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-14 21:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 14, Elevance Health rose 5.25% in pre-market trading, trading at $442.15/share, with turnover of $334,800. The rally came as multiple Wall Street firms issued bullish price target revisions just ahead of the company's Q2 earnings release scheduled for July 15.</p><p>On the news front, Wells Fargo significantly raised its price target from $391 to $492 while maintaining an Overweight rating; Truist lifted its target to $475, keeping a Buy rating; and Bernstein raised its target to $482, maintaining an Outperform rating. The FactSet consensus target price has climbed to approximately $439. Market consensus expects Q2 revenue of $48.714 billion, representing 0.99% year-over-year growth, with adjusted EPS of $6.20.</p><p>The broader healthcare insurance sector is approaching a critical test as Elevance, UnitedHealth, and CVS Health report Q2 results sequentially. Goldman Sachs noted that underwriting conditions for managed care companies are improving. Elevance delivered a strong Q1 beat with adjusted EPS of $12.58 versus the $10.79 estimate, and management reaffirmed full-year adjusted EPS guidance of at least $26.75.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ELV","symbol_name":"Elevance Health","start_time":0,"source_url":"","article_id":"1105657461","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1105657461","pubTimestamp":1784035572,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 14, Elevance Health rose 5.25% in pre-market trading, trading at $442.15/share, with turnover of $334,800. The rally came as multiple Wall Street firms issued bullish price target revisions...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ELV":"Elevance Health"},"translate_title":"走势警报|Elevance Health 在盘前交易中上涨 5.25%，多家投资银行在第二季度收益公布前上调目标价","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ELV":1},"content_text":"On July 14, Elevance Health rose 5.25% in pre-market trading, trading at $442.15/share, with turnover of $334,800. The rally came as multiple Wall Street firms issued bullish price target revisions just ahead of the company's Q2 earnings release scheduled for July 15.On the news front, Wells Fargo significantly raised its price target from $391 to $492 while maintaining an Overweight rating; Truist lifted its target to $475, keeping a Buy rating; and Bernstein raised its target to $482, maintaining an Outperform rating. The FactSet consensus target price has climbed to approximately $439. Market consensus expects Q2 revenue of $48.714 billion, representing 0.99% year-over-year growth, with adjusted EPS of $6.20.The broader healthcare insurance sector is approaching a critical test as Elevance, UnitedHealth, and CVS Health report Q2 results sequentially. Goldman Sachs noted that underwriting conditions for managed care companies are improving. Elevance delivered a strong Q1 beat with adjusted EPS of $12.58 versus the $10.79 estimate, and management reaffirmed full-year adjusted EPS guidance of at least $26.75.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}